Home › Funds › Atlas Venture Life Science Advisors, LLC › ODTX
Atlas Venture Life Science Advisors, LLC position in ODTX
Odyssey Therapeutics Inc · Health Care
Atlas Venture Life Science Advisors, LLC reported holding 2,692 shares of ODTX (Odyssey Therapeutics Inc) in its Q3 2026 13F filing — a position valued at US$60K, representing 0.01% of its reported portfolio and ranking #9 among its reported holdings. Atlas Venture Life Science Advisors, LLC first reported this position in Q3 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Atlas Venture Life Science Advisors, LLC's ODTX position evolved
Atlas Venture Life Science Advisors, LLC first disclosed a stake in ODTX in Q3 2026 at 2,692 shares (US$60K).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 2.69K | $59.82K | New |
About ODTX and 13F data
ODTX (Odyssey Therapeutics Inc) is a Health Care company. 76 other funds we track also report a position in ODTX — the largest reported positions include SR ONE CAPITAL MANAGEMENT, LP (US$71.0M), TPG GP A, LLC (US$69.0M), Lightspeed Management Company, L.L.C. (US$67.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ODTX
- SR ONE CAPITAL MANAGEMENT, LP 3.79M sh · $71.00M · Q2 2026
- TPG GP A, LLC 3.69M sh · $69.04M · Q2 2026
- Lightspeed Management Company, L.L.C. 3.61M sh · $67.51M · Q2 2026
- ORBIMED ADVISORS LLC 3.00M sh · $56.15M · Q2 2026
- Sanofi 1.99M sh · $44.22M · Q3 2026
- Sands Capital Alternatives, LLC 875.00K sh · $19.44M · Q3 2026
- Hillhouse Capital (HHLR Advisors) 831.66K sh · $15.56M · Q2 2026
- General Catalyst Group Management, LLC 810.27K sh · $15.16M · Q2 2026
- Affinity Asset Advisors, LLC 766.35K sh · $14.34M · Q2 2026
- Foresite Capital Management V, LLC 713.11K sh · $13.34M · Q2 2026
- Vivo Capital, LLC 575.00K sh · $12.78M · Q3 2026
- EcoR1 Capital, LLC 555.55K sh · $10.39M · Q2 2026
More on Atlas Venture Life Science Advisors, LLC
FAQ
How long has Atlas Venture Life Science Advisors, LLC held ODTX?
Atlas Venture Life Science Advisors, LLC has disclosed ODTX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Atlas Venture Life Science Advisors, LLC's current position in ODTX?
As of Q3 2026, Atlas Venture Life Science Advisors, LLC holds 2.69K shares of ODTX (Odyssey Therapeutics Inc), valued at $59.82K, representing 0.01% of its reported portfolio and ranking #9.
Has Atlas Venture Life Science Advisors, LLC been buying or selling ODTX?
In the latest 13F filing (Q3 2026), Atlas Venture Life Science Advisors, LLC newly opened its position in ODTX.
Which other funds hold ODTX?
Other major institutional holders of ODTX include SR ONE CAPITAL MANAGEMENT, LP, TPG GP A, LLC, Lightspeed Management Company, L.L.C., among 76 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.